Clinical Trials Expert in Contract Research Organizations
A clinical trials expert was sought to evaluate economic damages and losses suffered by a pharmaceutical manufacturer due to the actions of a contract research organization (CRO).
IMS ExpertServices was asked to find an expert in clinical trials familiar with the operations of contract research organizations. The expert would be required to opine as to the responsibilities of the contract research organization and clarify the potential losses involved with marketing strategies of new pharmaceuticals.
This pharmaceutical development expert has over 25 years of experience as a toxicologist, statistical consultant, and manager of research and development in the biotechnology, medical device, pharmaceutical and chemical industries. He is experienced in clinical trial development and study design, conduct and reporting and in the statistical analysis of both experimental and clinical trial data. IMS Reference #1218780
This clinical trial expert was president and cofounder of a public pharmaceutical company that develops and markets medical products for patients with uncommon diseases. He is well known as the author of 15 books on clinical trial methods, drug development processes, and discovery. These books are considered by many as the standard references on clinical trials and drug development. He has worked at four major pharmaceutical companies over 20 years in medicine discovery, drug development, and management. IMS Reference #5010514
This expert is president and founder of a contract research organization that provides consulting expertise in pharmacology, toxicology, therapeutics, biotechnology, drug development processes and regulatory affairs to pharmaceutical companies, governmental agencies and law firms. He has over 30 years of experience in pharmacology, toxicology, drug development processes and regulatory affairs. He has also directed global clinical trials at major multi-national pharmaceutical companies. IMS Reference #5010879